CONTOUR®NEXT ONE and CONTOUR®PLUS ONE blood glucose meters from Ascensia Diabetes Care are first to meet new DTSec cybersecurity standard
May 23, 2017—Given today's increasingly challenging cybersecurity requirements, we are pleased to announce that Ascensia Diabetes Care's CONTOUR®NEXT ONE and CONTOUR®PLUS ONE blood glucose meters have been successfully certified as meeting the recently developed DTS Cybersecurity Standard for Connected Diabetes Device Security (DTSec). Dr. David Klonoff (Diabetes Research Institute at Mills-Peninsula Health and Chair of the DTSec Steering Committee) revealed the news at this week's MEDSec: Security and Privacy for the Internet of Medical Things conference in San Jose, CA, demonstrating another important step forward in improving cybersecurity for people living with diabetes.
Evaluated and certified by the external security firm BrightSight, the world's largest independent security evaluator for high-criticality electronic products, the CONTOUR®NEXT ONE and CONTOUR®PLUS ONE meters are the first devices of their kind to be certified to meet the rigorous DTSec cybersecurity standard. Ascensia has made recent updates to the software on these meters to improve cybersecurity and enable them to meet these requirements. DTSec has been pioneered by the Diabetes Technology Society (DTS) in order to raise confidence in the security of network-connected medical devices. It uses a framework that is based on IS0/IEC 15408 to evaluate the security of medical devices, software, and systems.